Medulloblastoma Therapy
Studies from University of Leipzig, Institute of Clinical Immunology and Transfusion Medicine further understanding of medulloblastoma therapy
Published in Immunotherapy Weekly, December 5th, 2007
A report, 'Cytogenetic and molecular biological characterization of an adult medulloblastoma,' is newly published data in Cancer Genetics and Cytogenetics. "Medulloblastoma is a malignant invasive embryonal tumor, occurring in children mainly. It is rare in adults (<1% of adult brain tumors), and so comprehensive cytogenetic and molecular biological data on adult medulloblastomas are very limited," scientists in Leipzig, Germany report.
"Conventional therapies provide disappointing long-term disease control, and new therapeutic options are being tested. We performed comprehensive cytogenetic analyses of an adult medulloblastoma, WHO grade IV, using...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Immunotherapy Weekly
Source: Immunotherapy Weekly (2007-12-05)
More Articles from Immunotherapy Weekly
- Allergic Reactions
Protein suppresses allergic response in mice - Adrenal Cancer
Data on adrenal cancer described by researchers at Osaka University, Medical Department - Adverse Drug Reactions
Research on adverse drug reactions published by A. Debes et al - Alcoholism
Studies from Fukuoka University, Medical Department reveal new findings on alcoholism - Angiogenesis
Data on angiogenesis published by H.M.W. Verheu and colleagues - Angiogenesis
Research Uncovers Molecular Function of Endosialin Target of MORAb-004, Anti-Angiogenic Antibody Being Evaluated for Cancer, Neovascular Disease - More from this issue of Immunotherapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
